Bryce Point Capital LLC Has $687,000 Position in Evolent Health, Inc $EVH

Bryce Point Capital LLC cut its holdings in Evolent Health, Inc (NYSE:EVH) by 35.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 61,044 shares of the technology company’s stock after selling 33,417 shares during the period. Bryce Point Capital LLC owned approximately 0.05% of Evolent Health worth $687,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently made changes to their positions in the business. Nisa Investment Advisors LLC raised its position in shares of Evolent Health by 88.0% in the 2nd quarter. Nisa Investment Advisors LLC now owns 2,551 shares of the technology company’s stock worth $29,000 after acquiring an additional 1,194 shares in the last quarter. Parallel Advisors LLC increased its position in Evolent Health by 82.6% in the 2nd quarter. Parallel Advisors LLC now owns 3,487 shares of the technology company’s stock valued at $39,000 after buying an additional 1,577 shares in the last quarter. Banque Cantonale Vaudoise bought a new stake in Evolent Health in the 1st quarter valued at about $25,000. Rhumbline Advisers increased its position in Evolent Health by 2.1% in the 1st quarter. Rhumbline Advisers now owns 169,918 shares of the technology company’s stock valued at $1,609,000 after buying an additional 3,527 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Evolent Health by 2.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 128,527 shares of the technology company’s stock valued at $1,217,000 after buying an additional 3,572 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Truist Financial boosted their target price on Evolent Health from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Thursday, July 17th. Stephens reaffirmed an “equal weight” rating and issued a $9.00 target price on shares of Evolent Health in a research report on Wednesday, September 24th. BTIG Research reaffirmed a “buy” rating and issued a $20.00 target price on shares of Evolent Health in a research report on Tuesday, September 30th. Canaccord Genuity Group reissued a “buy” rating and set a $16.00 price objective on shares of Evolent Health in a report on Tuesday, September 9th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Evolent Health in a report on Wednesday, October 8th. Twelve equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $15.85.

Evolent Health Price Performance

Shares of NYSE EVH opened at $6.53 on Wednesday. The stock has a fifty day simple moving average of $8.40 and a two-hundred day simple moving average of $9.11. Evolent Health, Inc has a 1-year low of $6.49 and a 1-year high of $25.22. The firm has a market cap of $766.75 million, a price-to-earnings ratio of -4.05 and a beta of 0.66. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.72.

Evolent Health (NYSE:EVH) last posted its earnings results on Tuesday, June 4th. The technology company reported $0.21 earnings per share (EPS) for the quarter. Evolent Health had a positive return on equity of 1.83% and a negative net margin of 5.94%.The firm had revenue of $427.70 million for the quarter. Analysts anticipate that Evolent Health, Inc will post 0.08 earnings per share for the current year.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.